Life-threatening veno-occlusive disease after living-related liver transplantation.
D001379:Azathioprine / Q000627:therapeutic use; D005190:Family; D017809:Fatal Outcome; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006504:Hepatic Veno-Occlusive Disease / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects*; D019520:Living Donors; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D007166:Immunosuppressive Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide; D001379:Azathioprine